Sign in Sign up for free

OncoSec Medical Inc EPS Q/Q

What is the EPS Q/Q of OncoSec Medical Inc?

The EPS Q/Q of OncoSec Medical Inc is 1,700.00%

What is the definition of EPS Q/Q?



Quarterly EPS growth rate, year over year, is the increase of the company’s EPS for the most recent quarter compared to the the same quarter in the previous year.

quarterly growth yoy (year over year)

The earnings per share growth rate is an important factor for judging a company's value. EPS growth rate gives a good picture of the rate at which the company has grown its profitability in respect to the total number of shares. Comparing EPS history with stock price history helps determine the most likely future direction of the stock price.

Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.

EPS Q/Q of companies in the Health Care sector on NASDAQ compared to OncoSec Medical Inc

What does OncoSec Medical Inc do?

oncosec is a san diego-based biotechnology company pioneering new technologies to stimulate the body’s immune system to target and attack cancer. through our proprietary technology, we hope to deliver safer and more effective cancer treatments that can provide long-term benefits for patients. our technology, immunopulse™, is designed to enhance the local delivery and uptake of dna-based immune-targeting agents, such as il-12. clinical trials of immunopulse™ il-12 demonstrated a favorable safety profile and evidence of anti-tumor activity in the treatment of various skin cancers as well as the potential to initiate a systemic immune response. our lead program, immunopulse™ il-12, is currently in phase ii development for several indications, including metastatic melanoma, squamous cell carcinoma of the head and neck, and triple-negative breast cancer. to date, study results have laid the groundwork for the expansion into new dna-encoded therapeutic candidates and tumor indications. we ar

Companies with eps q/q similar to OncoSec Medical Inc